A Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management. SAE clinical review/causality Assessment and Sign off
|
|
- Myrtle Wright
- 5 years ago
- Views:
Transcription
1 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of Legend Use this legend to complete the Duties column. For each individual listed in the Name column, enter the letter(s) (e.g. a, c, e) from the legend below that correspond to their trial-related duties. If there are significant protocol related duties that are not already included in the legend, add them in the empty spaces provided below. Refer to reverse for further guidance. Neonatal Staff Pharmacy Staff A Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management B Assessment of eligibility H SAE clinical review/causality Assessment and Sign off N Completion of Stock Balance Log C Obtain Informed Consent I O D Randomisation J P E Prescribe Investigational Medicinal product (IMP) K Q F Provision of local ELFIN training L R The Investigator should sign below during the Site Close-Out Visit. I have reviewed the information on this log and have found it to be accurate. All delegated duties were performed with my authorisation. Investigator : Site Close-Out Visit Date: ELFIN Site Delegation Log Version 2 18/9/2015
2 Guidelines on ELFIN Training and Delegation (Review in conjunction with Trust policy) The ELFIN trial is being carried out in large neonatal units and involves potentially many staff providing care for trial participants. It is recognised that the provision of GCP training to all staff may not be feasible, leading to these guidelines. A tiered system is outlined in which GCP-trained doctors and nurses disseminate training, including the practical application of GCP principles as these apply to study-specific tasks. These tasks are frequently aspects of standard care (such as giving an oral medicine) that have been adapted to form part of the trial protocol. The diagram below is indicative of the pragmatic approach proposed to ensure all staff are appropriately supervised, trained and delegated for the tasks or duties that they perform when taking part in ELFIN. Investigator Local Research Nurse With responsibility for training Specific guidelines on delegation and training at recruiting sites are as follows: GCP training for the Investigator (PI) and Local Research Nurse (LRN) is mandatory. It is expected that GCP training be maintained in line with the policy of the participating Trust. Responsibility for disseminating training should be delegated by the PI to the LRN (or other appropriate team member) once they are satisfied that they can deliver the training effectively. It is expected that trainers be GCP-trained where they are training other staff expected to have GCP to perform that task. The initial delegation log returned to the ELFIN Coordinating Centre must include at minimum the Local Research Nurse (LRN), a person delegated responsibility for training locally (if not the LRN or Investigator) and a pharmacist or pharmacy technician with responsibility for managing the stock of IMP in the pharmacy. Staff taking consent must be trained in GCP and have received ELFIN study-specific training in consent evidenced on the ELFIN Training Log. CVs and GCP certificates to staff taking consent should be sent to the coordinating centre when they are added to the delegation log. Non-GCP trained Nurses Prepare and administer IMP Other GCP trained staff Non-GCP trained Doctors Prescribing of IMP Training packages are provided to support recruiting and continuing care site staff to understand the background and tasks involved in the ELFIN trial. The packages are designed to encourage a uniformity in the training provision across the sites in this multi-centre trial. The ELFIN Training Log will indicate the training packages required, depending on the level of involvement of each staff group. Staff prescribing ELFIN investigational medicinal product must have received study-specific training in prescribing, evidenced on the ELFIN Training Log, prior to prescribing IMP. They should be listed on the delegation log as prescribers, but may not necessarily have GCP training (e.g. junior medical staff). It is expected that a potentially large number of nurses will be involved in the preparation and administration of ELFIN investigational medicinal product (IMP). These nurses are not expected to be GCP trained and need not be listed on the delegation log. However they must have received study-specific training evidenced on the ELFIN Training Log prior to preparing or administering IMP. (Guidelines on ELFIN Training and Delegation Version 1 10/09/2015)
3 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
4
5 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
6
7 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
8
9 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
10
11 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
12
13 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
14
15 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
16
17 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
18
19 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
20
21 Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants Page: of This log should include all relevant trial staff and other clinical staff who routinely carry out trial procedures or who have specific data collection/interpretation duties. Add new or replacement staff as appropriate. Please send updated copies to the ELFIN Co-ordinating Centre. Note: Please complete the log and obtain the PI s approval before starting trial duties. Delegated Individual investigator Full Name (Please print) Role Duties (Use codes listed page 1) From Date of duties End address Usual Initials PI s Date ELFIN Site Delegation Log Version 2 18/9/2015
22
Prescribing Lactoferrin in the ELFIN Clinical trial
Prescribing Lactoferrin in the ELFIN Clinical trial PAULA JENKINS RESEARCH NURSE NPEU Why Lactoferrin is deemed an Investigational Medicinal Product any substance or combination of substances presented
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationI2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator
I2S2 TRAINING Good Clinical Practice tips Deirdre Thom Neonatal Nurse Coordinator Content Principal investigator (slides 3-5) Delegation and delegation log (slides 6-7) Informed consent (slides 8-15) Data
More informationPREDNOS 2 Newsletter. randomised controlled trial (RCT).
PREDNOS 2 Newsletter Issue 18 December 2017 Full Title: Short course daily prednisolone therapy at the time of upper respiratory tract infection (URTI) in children with relapsing steroid sensitive nephrotic
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationProgress Review. Launch Meeting 3 rd April 2014, Lucas House, Birmingham
Progress Review Launch Meeting 3 rd April 2014, Lucas House, Birmingham Who s involved? Grant - NIHR/MRC Efficacy and Mechanism Evaluation (EME) Programme - Approved 2 nd May 2013, Started 1 st Feb 2014
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationCancer Research UK Clinical Trials/Research Unit Glasgow. Quality System
Cancer Research UK Clinical Trials/Research Unit Glasgow Quality System BEATSON WEST OF SCOTLAND CANCER CENTRE POLICY ON THE AWARENESS AND TRAINING OF STAFF MANAGING PATIENTS WITHIN THE CONTEXT OF A CLINICAL
More informationGovernance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise
Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version
More informationCOMPETENCY FRAMEWORK
COMPETENCY FRAMEWORK Theresa Ledger Lead Nurse Research and Development Clinical Research Facility Sheffield C:\Documents and Settings\Robertus\My Documents\Mariann\CRF\CRF Portfolio and Competency Template_DRAFT
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationSOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227
SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:
More informationJOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.
JOB DESCRIPTION JOB TITLE: Pharmacy Technician Haematology Clinical Trials PAY BAND: Agenda for change - Band 5 TERMS AND CONDITIONS DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PROFESSIONALLY RESPONSIBLE
More informationThis Agreement dated DD/MM/YYYY (the Effective Date ) is between
Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationJoint R&D Support Office SOP S-2011 UHL
UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for
More informationSetting up a Clinical Trial
York Foundation Trust R&D Unit SOP Pharm/S45 Setting up a Clinical Trial IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING USED All staff should regularly check
More informationDocument Title: Study Data SOP (CRFs and Source Data)
Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationNIHR Medicines for Children Research Network Response January 2010
NIHR Medicines for Children Research Network response Introduction The National Institute for Health Research (NIHR) Medicines for Children Research Network (MCRN) is part of the National Institute for
More informationReference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015
Reference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015 Safety Reporting in CTIMPs Standard Operating Procedure Introduction and Aim The
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number End of Study Report SOP-RES-027 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Natalie
More informationRITAZAREM CRF Completion Guidelines
RITAZAREM CRF Completion Guidelines 10 Sept 2013 Version 1.2 Author: Michelle Lewin RITAZAREM Trial Coordinator Michelle.lewin@addenbrookes.nhs.uk Tel: +44(0) 1223 349350 Fax: +44(0) 1223 586767 Version
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationOFFICE FOR RESEACH PROCEDURE. Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records
OFFICE FOR RESEACH PROCEDURE Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records 1. Purpose: To describe the procedures related to the appropriate documentation
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationCommission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo
Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics 30.1.2017 Oslo 3.2.2017 O. Konttinen 1 Background Based on directive 2001/20/EC of the clinical trials on medicinal
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationSite Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG
Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG INFORMATION AND GUIDANCE SHEET FOR THE COMPLETION OF THE SITE SIGNATURE AND
More informationQUALITY ASSURANCE PROGRAM
QUALITY ASSURANCE PROGRAM Elaine Armstrong, MS Quality Assurance Manager PURPOSE Verify accuracy of submitted data Verify compliance with protocol and regulatory requirements Provide educational support
More informationMarie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance processing for the JRMO SOP Number: 26c Version Number: V1 Effective Date: 5/8/16 Review Date: 5/8/17 Author: Reviewer: Reviewer: Authorisation:
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)
More informationSTH Researcher. Recording of research information in patient case notes
STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date
More informationStatement of Responsibilities
Statement of Responsibilities Full Title: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm
More informationEuropean Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS
European Medicines Agency Inspections London, 23 July 2008 EMEA/INS/GCP/197215/2005 Procedure no.: INS/GCP/3/V ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS GCP
More informationSTANDARD OPERATING PROCEDURE SOP 205
STANDARD OPERATING PROCEDURE SOP 205 Adverse Events: Identifying, Recording and Reporting for CTIMPs Sponsored by the Norfolk and Norwich University Hospital NHS Foundation Trust Version 2.3 Version date
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationR. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Adverse Event Identification, Recording and Reporting in Clinical Trials of Investigational Medicinal SOP-RES-019 Version Number 2 Issue Date 08 th Dec
More informationSOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head
More informationSurvey of Research Nurse Training and Experience in a Paediatric Clinical Trial Setting
Survey of Research Nurse Training and Experience in a Paediatric Clinical Trial Setting The following survey has been generated by the European Network of Paediatric Research at the European Medicines
More informationPERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL ADJUSTMENT PROCESS HRA APPROVED TRIALS
PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL ADJUSTMENT PROCESS HRA APPROVED TRIALS Version Control Pages 7 9 Notes/action column updated 1 Acronyms CTP DSC DSS FPR HRA MHRA REC SOP
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationStandard Operating Procedures
Standard Operating Procedures 5.7 Site Initiation Version V1.0 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 30/09/2017 Review date 30/09/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT
More informationThe role of pharmacy in clinical trials it s not just counting pills. Michelle Donnison, Senior Pharmacy Technician, York Hospital
The role of pharmacy in clinical trials it s not just counting pills Michelle Donnison, Senior Pharmacy Technician, York Hospital I am currently employed as a Senior Pharmacy Technician working at York
More informationResearch Staff Training
REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:
More informationMedicines Management for Dietitians. Sue Kellie Head of Education and Professional Development The British Dietetic Association
Medicines Management for Dietitians. Sue Kellie Head of Education and Professional Development The British Dietetic Association Aim of presentation. To give an overview of the current legislation surrounding
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Maintaining Training Records SOP Number: 20 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date:
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationDocument Title: Investigator Site File. Document Number: 019
Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationPERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES
PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 20 Items 22, 23 Item 27 Added item regarding responsibility of providers to submit successfully
More informationOnce the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More informationStandard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research
Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationAPPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS
APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS Use the following checklists in the appropriate areas of your office, facility or practice to assist in preventing medications errors:
More informationSheffield Teaching Hospitals NHS Foundation Trust Pharmacy Services Research Strategy 2015/2016
Sheffield Teaching Hospitals NHS Foundation Trust Pharmacy Services Research Strategy 2015/2016 1. Introduction As recently as five years ago, the pharmacy directorate s research activity was almost entirely
More informationVCU Clinical Research Quality Assurance Assessment
VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment
More informationDANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:
POLICY #: EDU-100 Page: 1 of 5 1. POLICY STATEMENT: Individuals who participate in research activities overseen by DF/HCC must satisfy specific training requirements in order to conduct human subject research.
More informationEffective Date: 11/09 Policy Chronicle:
Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:
More informationChecklist prior to recruiting first patient
Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF Checklist prior to recruiting first patient
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationSTUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)
POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationMANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic
More informationResearch Adverse Event and Safety Reporting Procedures Outcome Statement: Title:
Title: Research Adverse Event and Safety Reporting Procedures Outcome Statement: Research Teams will be able to correctly identify and report Adverse Events and complete Annual Safety Reports for research
More informationAdverse Event Reporting
Adverse Event Reporting The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.thh.nhs.uk/departments/research/research.htm
More information1. INTRODUCTION 2. SCOPE 3. PROCESS
1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of
More informationTRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
More informationJob Description. Clinical Nurse Specialist in Tissue Viability
Job Description Job Title: Grade: Hours: Reporting relationships: Clinical Nurse Specialist in Tissue Viability Clinical Nurse Specialist 19.5 hours per week Professionally accountable to the Director
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationAdverse Event Reporting
Adverse Event Reporting Clinical S.O.P. No.: 15 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited Date edited number by 1.0 New SOP
More informationVerification List. New Trial. XML (if not present, request to applicant) Receipt of confirmation of the EUDRACT number. Cover Letter.
Verification List New Trial EudraCT number: CEIC number: Done by: Start : Valid End : Not Valid Task Number XML (if not present, request to applicant) Receipt of confirmation of the EUDRACT number Receipt
More informationIDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES
IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES DOCUMENT NO.: CR012 v2.0 AUTHOR: Raymond French ISSUE DATE: 18 September 2017 EFFECTIVE DATE: 02 October
More informationComprehensive Protocol Feasibility Questionnaire
Protocol Title: Potential Principal Investigator: Regulatory Coordinators: Department Chair: PROJECT FEASIBILITY PI and Study Team: YOUR RESPONSES TO THIS SURVEY CONSTITUTE A BEST ESTIMATE OF RESOURCES
More informationStorage and Archiving of Research Documents SOP 6
Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager
More informationCorporate. Research Governance Policy. Document Control Summary
Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:
More information